While aromatherapy is backed by legitimate science and has clear therapeutic benefits, the field is currently at risk. Because the industry often uses language in ways that contradict broader scientific standards, it is frequently vulnerable to being dismissed as "pseudoscience." This isn't just a matter of reputation; it poses a risk of professional "demarcation," in which more established, authoritative medical fields actively work to invalidate or limit the practice of aromatherapy....

Defining evidence-based practice The dismissal of ‘evidence-based’ Aromatherapy as a failed or meaningless metric – often by those who narrowly define evidence as a binary of randomized controlled trials (RCTs) – betrays a fundamental misunderstanding of clinical methodology. The term “evidence-based” is frequently hijacked to mean only randomized controlled trials (RCTs), but in a clinical setting, that is a narrow and often impractical definition. True evidence-based practice (EBP) is a...

The cost of misinformation The Aromatherapy industry currently navigates a difficult landscape between clinical validation and an "infodemic" of uneducated advice. When practitioners suggest protocols based on personal anecdotes rather than chemistry, the safety of the entire field is compromised. When a user experiences an adverse reaction, such as sensitization or a chemical burn, they rarely blame the individual’s poor advice; instead, they conclude that "Aromatherapy doesn’t work,"...